REGULATED PRESS RELEASE published on 11/14/2024 at 18:01, 1 year 11 months ago EMOVA GROUP - Volume d'affaires T4 2023-24 Emova Group annonce une croissance de 1,05% en France et un volume d'affaires de 124,6 M€ en 2023/2024, dépassant les attentes EMOVA GROUP Croissance Performance France Volume D'affaires
BRIEF published on 09/05/2024 at 18:06, 2 years 1 month ago EMOVA GROUP - Business volume Q3 2023-24 EMOVA GROUP Business Volume France Franchise Q3 2023-24
BRIEF published on 09/05/2024 at 18:06, 2 years 1 month ago EMOVA GROUP - Volume d'affaires T3 2023-24 EMOVA GROUP France Franchise Volume D'affaires T3 2023-24
REGULATED PRESS RELEASE published on 09/05/2024 at 18:01, 2 years 1 month ago EMOVA GROUP - Volume d'affaires T3 2023-24 Emova Group affiche une croissance de +1,5% en France sur 9 mois, avec un volume d'affaires de 100,4 M€. Au T3 avril-juin 2024, la croissance est de +4,0% par rapport à N-1 EMOVA GROUP Croissance France Volume D'affaires T3
BRIEF published on 07/01/2024 at 18:06, 2 years 3 months ago Emova Group H1 2023/24 half-year results EMOVA GROUP EBITDA Half-year Results Turnover Streamlining Strategy
BRIEF published on 07/01/2024 at 18:06, 2 years 3 months ago Résultats semestriels S1 2023/24 d'Emova Group EMOVA GROUP Chiffre D'affaires Résultats Semestriels EBITDA Stratégie De Rationalisation
REGULATED PRESS RELEASE published on 07/01/2024 at 18:01, 2 years 3 months ago Emova Group - Résultats semestriels S1 2023/24 Emova Group annonce un chiffre d'affaires du S1 2023/24 de 14,8 M€, avec une marge d'EBITDA de 20,5%. Rationalisation du parc en succursale EMOVA GROUP Chiffre D'affaires EBITDA Rationalisation Succursale
BRIEF published on 04/25/2024 at 18:06, 2 years 5 months ago EMOVA GROUP annonce son volume d'activité pour le premier semestre 2023/24 Marchés Internationaux Volume D'activité Stabilité Du Marché Groupe Emova Ventes De Franchises
BRIEF published on 04/25/2024 at 18:06, 2 years 5 months ago EMOVA GROUP Reports First Half 2023/24 Business Volume EMOVA GROUP Business Volume International Markets Market Stability Franchise Sales
REGULATED PRESS RELEASE published on 04/25/2024 at 18:01, 2 years 5 months ago EMOVA GROUP - Volume d'affaires T2 et S1 2023-24 Emova Group reports 1st half 2023/2024 turnover of €64.3M, in line with previous year in France. Performance highlights resilience and brand strength EMOVA GROUP Turnover Résilience France 1st Half 2023/2024
Published on 10/23/2026 at 16:00, 37 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 3 hours 14 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 3 hours 37 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 3 hours 37 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 14 hours 17 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/23/2026 at 16:25, 11 minutes ago Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
Published on 10/23/2026 at 16:10, 26 minutes ago EQS-Adhoc: SGL Carbon sells its former Carbon Fiber facility in Moses Lake (USA)
Published on 10/23/2026 at 15:40, 56 minutes ago Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 07:00, 9 hours 37 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 22 hours 37 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 22 hours 37 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 22 hours 37 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
